Harmony Biosciences Holdings (HRMY) EBIT Growth (3y) (2022 - 2026)
Harmony Biosciences Holdings (HRMY) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -1,580.97% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 32.96% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -29.67% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 16.35% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -50.81% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 13.47% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -40.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.92% |
| Dec 31, 2025 | -66.55% |
| Sep 30, 2025 | 76.55% |
| Jun 30, 2025 | 13.31% |
| Mar 31, 2025 | 26.85% |
| Dec 31, 2024 | 24.86% |
| Sep 30, 2024 | 43.11% |
| Jun 30, 2024 | -2.88% |
| Mar 31, 2024 | 52.98% |
| Dec 31, 2023 | 73.04% |
| Sep 30, 2023 | 83.85% |
| Jun 30, 2023 | 85.83% |
| Mar 31, 2023 | 83.78% |
| Dec 31, 2022 | 50.56% |
| Sep 30, 2022 | 33.87% |